Sudden infant death syndrome (SIDS) is a tragic occurrence that is the leading cause of death among babies from 1 month to 1 year old in the U.S. Babies affected by SIDS appear healthy but die suddenly, often in their sleep, with no clear explanation. A study published in JAMA Pediatrics found that certain metabolites identified in routine newborn screenings could potentially indicate babies at an elevated risk for SIDS.
The study, conducted from 2005 to 2011 on infants born in California, found that infants with particular levels of these metabolites had up to 14 times the odds of developing SIDS compared to infants with the lowest risk. These metabolites are produced as the body breaks down nutrients, indicating potential metabolic differences in babies at higher risk.
While the research suggests that babies who die unexpectedly may be metabolically different, more investigation is needed to understand the link between metabolism and SIDS risk. Despite these findings, preventing SIDS remains challenging, and it is unclear what actions can be taken if abnormal metabolic profiles are detected in newborn screenings.
Experts believe that SIDS likely results from a combination of factors, including genetic, metabolic, and neurological issues. Past studies have highlighted risk factors such as serotonin abnormalities and autonomic nervous system dysfunction, suggesting a complex interplay of systems involved in SIDS. It remains to be seen how metabolic differences identified in this study align with previously identified neurological differences, emphasizing the need for further research to fully understand the underlying causes of SIDS.
Photo credit
www.nbcnews.com